INNODIA is an international non-for-profit organization that accelerates the development of therapies to prevent and cure type 1 diabetes. INNODIA convenes entities often with different incentives but united in the desire to address the same unifying unmet medical need: the lack of definitive cures for people living with type 1 diabetes.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Ku Leuven, Leuven,uz Herestraat 3000,belgium
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.innodia.org/
- Keywords
- Research, Diabetes, Type 1 diabetes, T1D, Public private partnership, Clinical research, laboratories, Pharmaceuticals, Patient voice matters, screening for T1D, Medicine Developers.
- HQ
- Leuven, UZ Herestraat
Innodia Questions
Innodia's website is https://www.innodia.org/
Innodia's LinkedIn profile is https://be.linkedin.com/company/innodia
Innodia has
23 employees.
View email and phone details for 23
employees at Innodia.
Innodia's industry is
Research Services
Innodia's top competitors are
Edent1fi,
Eupati,
European Association For The Study Of Diabetes E.v. (Easd),
Pt Innovasi Diagnostika,
Innovative Health Initiative (Ihi),
Levicure,
Diamyd Medical,
Diaunion,
Breakthrough T1d,
Jdrf International.
Innodia's categories are Research Services
Innodia's founding year is 2022
